» Articles » PMID: 36336765

Extranodal T- and NK-cell Lymphomas

Overview
Journal Virchows Arch
Date 2022 Nov 6
PMID 36336765
Authors
Affiliations
Soon will be listed here.
Abstract

Non-cutaneous extranodal NK/T cell lymphoproliferations constitute a heterogenous group of rare neoplasms, occurring primarily in the gastro-intestinal tract, nasal area, spleen, and liver. Their nomenclature refers to their usual clinical presentation and predilection for specific anatomic sites-i.e. extranodal NK/T-cell lymphoma, nasal-type, hepatosplenic T-cell lymphoma, primary intestinal T-cell lymphomas, indolent lymphoproliferative disorders of the gastrointestinal tract, and breast implant-associated anaplastic large cell lymphoma. Extranodal tissues may also be involved by T-cell leukemias, or other entities usually presenting as nodal diseases. Primary extranodal entities range from indolent to highly aggressive diseases. Here, we will review the clinicopathologic features of the pertinent entities including the recent advances in their molecular and genetic characterization, with an emphasis on the changes introduced in the 2022 International Consensus Classification of lymphoid neoplasms, and highlight the diagnostic criteria helpful to sort out the distinction with potential mimickers.

Citing Articles

A novel prognostic model utilizing TMTV and SUVmax from F-FDG PET/CT for predicting overall survival in patients with extranodal NK/T- cell lymphoma.

Wang H, Feng D, Mo Y, Hong H, Hu Y, Huang L BMC Cancer. 2025; 25(1):383.

PMID: 40033269 PMC: 11874801. DOI: 10.1186/s12885-025-13725-9.


Comparison of clinical features of patients with or without severe gastrointestinal complications in aggressive gastrointestinal lymphomas.

Liu X, Chen G, Cao D, Liu H, Ke X, Hu Y World J Gastrointest Oncol. 2024; 16(11):4409-4423.

PMID: 39554739 PMC: 11551637. DOI: 10.4251/wjgo.v16.i11.4409.


Rare extranodal NK/T-cell lymphoma: a diagnostic challenge and therapeutic approach.

Moura de Azevedo S, Sousa F, Peixeiro R, Bertao M Porto Biomed J. 2024; 9(6):274.

PMID: 39544843 PMC: 11560117. DOI: 10.1097/j.pbj.0000000000000274.


Progressive necrotic mass of the midline face.

Gravell C, Mpunga N, Messer A, Diaz Duque A JAAD Case Rep. 2024; 53:13-16.

PMID: 39430633 PMC: 11490667. DOI: 10.1016/j.jdcr.2024.06.024.


Impact of prior cancer history on the prognosis of extranodal NK/T-cell lymphoma.

Wang Q, Huang T, Wei X PLoS One. 2024; 19(10):e0311094.

PMID: 39413080 PMC: 11482683. DOI: 10.1371/journal.pone.0311094.


References
1.
Lee G, Ryu H, Choi J, Kang H, Yang W, Yang I . Characteristic gene alterations in primary gastrointestinal T- and NK-cell lymphomas. Leukemia. 2019; 33(7):1797-1832. PMC: 6755973. DOI: 10.1038/s41375-018-0309-4. View

2.
Margolskee E, Jobanputra V, Lewis S, Alobeid B, Green P, Bhagat G . Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features. PLoS One. 2013; 8(7):e68343. PMC: 3701677. DOI: 10.1371/journal.pone.0068343. View

3.
Ettersperger J, Montcuquet N, Malamut G, Guegan N, Lopez-Lastra S, Gayraud S . Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease. Immunity. 2016; 45(3):610-625. DOI: 10.1016/j.immuni.2016.07.018. View

4.
Carbonnel F, dAlmagne H, Lavergne A, Matuchansky C, Brouet J, Sigaux F . The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut. 1999; 45(5):662-7. PMC: 1727728. DOI: 10.1136/gut.45.5.662. View

5.
Bisig B, Cairoli A, Gaide O, Somja J, Bregnard C, Gaulard P . Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation. Virchows Arch. 2022; 481(4):653-657. DOI: 10.1007/s00428-022-03309-4. View